Eurofound's EU PolicyWatch collates information on the responses of government and social partners to the COVID-19 crisis, the war in Ukraine, rising inflation, as well as gathering examples of company practices aimed at mitigating the social and economic impacts.
Factsheet for measure LV-2020-50/1587 – Updated – measures in Latvia
Country | Latvia , applies nationwide |
Time period | Open ended, started on 07 December 2020 |
Context | COVID-19 |
Type | Company practices |
Category |
Reorientation of business activities
– Change of production/Innovation |
Author | Kriss Karnitis (EPC) and Eurofound |
Measure added | 09 December 2020 (updated 25 February 2021) |
E. Gulbja laboratory in cooperation with JK Energo Ltd. and Latvijas Finieris Jsc. has created an innovative contactless clinical analysis collection machine. On 7 December 2020, the first of these machines were installed at Pauls Stradins Clinical University Hospital for regular COVID-19 testing material collection of the hospital staff. From 14 December 2020, additional machines will be installed elsewhere and made available to the public.
An innovative contactless analysis collection device has been created by E.Gulbis laboratory in cooperation with JK Energo Ltd. and Latvijas Finieris Jsc. The device from the idea to the installation was created by Latvian specialists and companies, emphasized Didzis Gavars, a member of the board of E. Gulbis laboratory. The machine is fully automated and its software provides remote machine management.
It is expected that the new device will significantly save time for both laboratory and hospital staff, ensure faster test results and reduce the risk of infection.
In future the company plans that also other than COVID-19 testing material could be collected with the machine.
The following updates to this measure have been made after it came into effect.
27 January 2021 |
Until 27 January 2021, E. Gulbja laboratory has placed contactless clinical analysis collection machines in four more places. |
No information to report.
Workers | Businesses | Citizens |
---|---|---|
Does not apply to workers | Does not apply to businesses | Does not apply to citizens |
Actors | Funding |
---|---|
Company / Companies
|
Companies
|
Social partners' role in designing the measure and form of involvement:
Trade unions | Employers' organisations | |
---|---|---|
Role | No involvement as case not in social partner domain | No involvement as case not in social partner domain |
Form | Not applicable | Not applicable |
Social partners' role in the implementation, monitoring and assessment phase:
No social partners involvement.
No specific views to report.
This case is sector-specific
This case is not occupation-specific.
Citation
Eurofound (2020), E. Gulbja laboratory creates automated analysis collection machine, measure LV-2020-50/1587 (measures in Latvia), EU PolicyWatch, Dublin, https://static.eurofound.europa.eu/covid19db/cases/LV-2020-50_1587.html
Share
30 January 2023
Governments across the EU continue to implement policies to support citizens and businesses in the face of rising food and energy prices caused by the COVID-19 crisis and intensified by the war in Ukraine. This article summarises the policy responses as reported in Eurofound's EU PolicyWatch database from January to September 2022.
Article12 September 2022
Although the worldwide pandemic situation had already disrupted supply chains and triggered increases in energy and food prices in 2021, the situation deteriorated in 2022 with the Russian invasion of Ukraine.
Article12 September 2022
This article summarises the first policy responses that governments across the EU have started to implement to support companies affected by the rising prices, and those with commercial ties to Ukraine, Russia or Belarus.
Article5 July 2022
This article summarises the first policy responses of EU Member States, including those of the social partners and other civil society actors, enabling refugees to exercise their rights under the Temporary Protection Directive.
ArticleDisclaimer: This information has not been subject to the full Eurofound evaluation, editorial and publication process.